Jackson Announces Third Quarter 2024 Results
Third quarter 2024 results reflect strong growth in sales, earnings, capital generation and capital return
-
Retail annuity sales of
$5.3 billion in the third quarter of 2024, up 59% from the third quarter of 2023-
Variable annuity sales of
$2.6 billion in the third quarter of 2024, up 8% from the third quarter of 2023 -
Record registered index-linked annuity (RILA) sales of
$1.6 billion in the third quarter of 2024, up 99% from the third quarter of 2023 -
Leveraging Jackson’s broad retail annuity distribution platform resulted in
$1 billion of fixed and fixed index annuity sales in the third quarter of 2024, up from$76 million in the third quarter of 2023
-
Variable annuity sales of
-
Earnings driven by an 18% increase in total annuity assets under management (AUM), from
$218 billion as ofSeptember 30, 2023 to$256 billion as ofSeptember 30, 2024 , largely due to higher equity markets -
Net income (loss) attributable to
Jackson Financial Inc. common shareholders of$(480) million , or$(6.37) per diluted share in the third quarter of 2024, primarily driven by a loss on reinsured business, compared to$2.8 billion , or$33.35 per diluted share in the third quarter of 2023 -
Adjusted operating earnings1 of
$350 million , or$4.60 per diluted share in the third quarter of 2024, compared to$315 million , or$3.80 per diluted share in the third quarter of 2023, driven largely by growth in variable annuity assets under management, higher spread income, and a reduction in the diluted share count due to common share repurchases -
Robust capital position at the operating company, with total adjusted capital of
$4.8 billion and an estimated risk-based capital (RBC) ratio atJackson National Life Insurance Company (JNLIC) of 550-570% as ofSeptember 30, 2024 , which also reflects the impact of a third quarter distribution by JNLIC of$300 million . Statutory capital generation over the first nine months of 2024 exceeded$1 billion . -
Returned
$167 million to common shareholders in the third quarter of 2024 through$113 million of common share repurchases and$54 million in common dividends. Capital return in the first nine months of 2024 totaled$483 million , or$6.24 per diluted share, up 52% from the first nine months of 2023. -
Cash and highly liquid securities at the holding company of nearly
$650 million as ofSeptember 30, 2024 , which was above Jackson’s$250 million minimum liquidity buffer
Consolidated Third Quarter 2024 Results
The Company reported net income (loss) attributable to
Adjusted operating earnings for the three months ended
Total common shareholders’ equity was
Segment Results – Pretax Adjusted Operating Earnings 3
|
Three Months Ended |
|
(in millions) |
|
|
Retail Annuities |
|
|
Institutional Products |
17 |
21 |
Closed Life and Annuity Blocks |
7 |
6 |
Corporate and Other |
(71) |
(26) |
Total3 |
|
|
Retail Annuities
Retail Annuities reported pretax adjusted operating earnings of
Total annuity sales of
Institutional Products
Institutional Products reported pretax adjusted operating earnings of
Closed Life and Annuity Blocks
Closed Life and Annuity Blocks reported pretax adjusted operating income of
Corporate and Other
Corporate and Other reported a pretax adjusted operating loss of
Capitalization and Liquidity
(Unaudited, in billions) |
|
|
|
|
|
Jackson National Life Insurance Company |
Statutory TAC at JNLIC was
Cash and highly liquid securities at the holding company totaled nearly
Earnings Conference Call
Jackson will host a conference call
To register for the webcast, click here.
FORWARD-LOOKING STATEMENTS
The information in this press release contains forward-looking statements about future events and circumstances and their effects upon revenues, expenses and business opportunities. Generally speaking, any statement in this release not based upon historical fact is a forward-looking statement. Forward-looking statements can also be identified by the use of forward-looking or conditional words, such as “could,” “should,” “can,” “continue,” “estimate,” “forecast,” “intend,” “look,” “may,” “will,” “expect,” “believe,” “anticipate,” “plan,” “remain,” “confident” and “commit” or similar expressions. In particular, statements regarding plans, strategies, prospects, targets and expectations regarding the business and industry are forward-looking statements. They reflect expectations, are not guarantees of performance and speak only as of the dates the statements are made. We caution investors that these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those projected, expressed or implied. Factors that could cause actual results to differ materially from those in the forward-looking statements include those reflected in Part I, Item 1A. Risk Factors and Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended
Certain financial data included in this release consists of non-GAAP (Generally Accepted Accounting Principles) financial measures. These non-GAAP financial measures may not be comparable to similarly titled measures presented by other entities, nor should they be construed as an alternative to other financial measures determined in accordance with
Certain financial data included in this release consists of statutory accounting principles (“statutory”) financial measures, including “total adjusted capital.” These statutory financial measures are included in or derived from the
ABOUT JACKSON
Jackson® (NYSE: JXN) is committed to helping clarify the complexity of retirement planning—for financial professionals and their clients. Through our range of annuity products, financial know-how, history of award-winning service* and streamlined experiences, we strive to reduce the confusion that complicates retirement planning. We take a balanced, long-term approach to responsibly serving all our stakeholders, including customers, shareholders, distribution partners, employees, regulators and community partners. We believe by providing clarity for all today, we can help drive better outcomes for tomorrow. For more information, visit www.jackson.com.
*SQM (
Jackson® is the marketing name for
WEBSITE INFORMATION
Visit investors.jackson.com to view information regarding
APPENDIX
Non-GAAP Financial Measures
In addition to presenting our results of operations and financial condition in accordance with
Adjusted Operating Earnings
Adjusted Operating Earnings is an after-tax non-GAAP financial measure, which we believe should be used to evaluate our financial performance on a consolidated basis by excluding certain items that may be highly variable from period to period due to accounting treatment under
For additional detail on the excluded items, please refer to the supplement regarding the third quarter ended
The following is a reconciliation of Adjusted Operating Earnings to net income (loss) attributable to
|
Three Months Ended |
|||||
(in millions, except share and per share data) |
2024 |
2023 |
||||
Net income (loss) attributable to |
$ |
(480 |
) |
$ |
2,762 |
|
Add: dividends on preferred stock |
|
11 |
|
|
11 |
|
Add: income tax expense (benefit) |
|
(113 |
) |
|
712 |
|
Pretax income (loss) attributable to |
|
(582 |
) |
|
3,485 |
|
Non-operating adjustments – (income) loss: |
|
|
||||
Guaranteed benefits and hedging results: |
|
|
||||
Fees attributable to guarantee benefit reserves |
|
(779 |
) |
|
(784 |
) |
Net (gains) losses on hedging instruments1 |
|
(591 |
) |
|
271 |
|
Market risk benefits (gains) losses, net |
|
1,172 |
|
|
(2,376 |
) |
Net reserve and embedded derivative movements |
|
493 |
|
|
(45 |
) |
Amortization of DAC associated with non-operating items at date of transition to LDTI2 |
|
135 |
|
|
148 |
|
Total guaranteed benefits and hedging results |
|
430 |
|
|
(2,786 |
) |
Net realized investment (gains) losses |
|
45 |
|
|
127 |
|
Net realized investment (gains) losses on funds withheld assets |
|
784 |
|
|
(159 |
) |
Net investment income on funds withheld assets |
|
(269 |
) |
|
(303 |
) |
Other items |
|
3 |
|
|
(9 |
) |
Total non-operating adjustments |
|
993 |
|
|
(3,130 |
) |
Pretax adjusted operating earnings |
|
411 |
|
|
355 |
|
Less: operating income tax expense (benefit) |
|
50 |
|
|
29 |
|
Adjusted operating earnings before dividends on preferred stock |
|
361 |
|
|
326 |
|
Less: dividends on preferred stock |
|
11 |
|
|
11 |
|
Adjusted operating earnings |
$ |
350 |
|
$ |
315 |
|
|
|
|
||||
Weighted Average diluted shares outstanding |
|
76,125,719 |
|
|
82,821,818 |
|
Net income (loss) per diluted share |
$ |
(6.37 |
) |
$ |
33.35 |
|
Adjusted Operating Earnings per diluted share |
$ |
4.60 |
|
$ |
3.80 |
|
1Includes |
||||||
2LDTI - Adoption of FASB issued ASU 2018-12 “Targeted Improvements to the Accounting for Long Duration Contracts”. |
Adjusted Book Value Attributable to Common Shareholders
Adjusted Book Value Attributable to Common Shareholders excludes Preferred Stock and Accumulated Other Comprehensive Income (Loss) ("AOCI") attributable to
(in millions) |
|
|
||
Total shareholders’ equity |
$ |
10,698 |
$ |
10,170 |
Less: Preferred equity |
|
533 |
|
533 |
Total common shareholders’ equity |
|
10,165 |
|
9,637 |
Adjustments to total common shareholders’ equity: |
|
|
||
Exclude Accumulated Other Comprehensive (Income) Loss attributable to |
|
1,047 |
|
1,196 |
Adjusted Book Value Attributable to Common Shareholders |
$ |
11,212 |
$ |
10,833 |
Condensed Consolidated Balance Sheets
|
|
|
|
|
|||
|
|
2024 |
|
2023 |
|||
(in millions, except share and per share data) |
|
|
|
|
|||
Assets |
|
|
|
|
|||
Investments: |
|
|
|
|
|
||
|
|
$ |
42,289 |
|
$ |
40,422 |
|
|
|
|
2,937 |
|
|
2,153 |
|
|
|
|
73 |
|
|
68 |
|
Equity securities, at fair value |
|
|
213 |
|
|
394 |
|
Mortgage loans, net of allowance for credit losses of |
|
|
9,564 |
|
|
10,082 |
|
Mortgage loans, at fair value under fair value option |
|
|
432 |
|
|
481 |
|
Policy loans (including |
|
|
4,453 |
|
|
4,399 |
|
Freestanding derivative instruments |
|
|
295 |
|
|
390 |
|
Other invested assets |
|
|
2,747 |
|
|
2,466 |
|
Total investments |
|
|
63,003 |
|
|
60,855 |
|
Cash and cash equivalents |
|
|
3,061 |
|
|
2,688 |
|
Accrued investment income |
|
|
528 |
|
|
512 |
|
Deferred acquisition costs |
|
|
11,986 |
|
|
12,302 |
|
Reinsurance recoverable, net of allowance for credit losses of |
|
|
22,959 |
|
|
25,422 |
|
Reinsurance recoverable on market risk benefits, at fair value |
|
|
149 |
|
|
149 |
|
Market risk benefit assets, at fair value |
|
|
7,615 |
|
|
6,737 |
|
Deferred income taxes, net |
|
|
527 |
|
|
640 |
|
Other assets |
|
|
797 |
|
|
1,294 |
|
Separate account assets |
|
|
235,037 |
|
|
219,656 |
|
Total assets |
|
$ |
345,662 |
|
$ |
330,255 |
|
Condensed Consolidated Balance Sheets
|
|
|
|
|
|
||||
|
|
2024 |
|
2023 |
|
||||
(in millions, except share and per share data) |
|
|
|
|
|
||||
Liabilities and Equity |
|
|
|
|
|||||
Liabilities |
|
|
|
|
|
||||
Reserves for future policy benefits and claims payable |
|
$ |
11,543 |
|
|
$ |
11,898 |
|
|
Other contract holder funds |
|
|
57,334 |
|
|
|
55,319 |
|
|
Market risk benefit liabilities, at fair value |
|
|
4,384 |
|
|
|
4,785 |
|
|
Funds withheld payable under reinsurance treaties (including |
|
|
18,103 |
|
|
|
19,952 |
|
|
Long-term debt |
|
|
2,033 |
|
|
|
2,037 |
|
|
Repurchase agreements and securities lending payable |
|
|
820 |
|
|
|
19 |
|
|
Collateral payable for derivative instruments |
|
|
124 |
|
|
|
780 |
|
|
Freestanding derivative instruments |
|
|
425 |
|
|
|
1,210 |
|
|
Notes issued by consolidated variable interest entities, at fair value under fair value option |
|
|
2,366 |
|
|
|
1,988 |
|
|
Other liabilities |
|
|
2,586 |
|
|
|
2,277 |
|
|
Separate account liabilities |
|
|
235,037 |
|
|
|
219,656 |
|
|
Total liabilities |
|
|
334,755 |
|
|
|
319,921 |
|
|
|
|
|
|
|
|
||||
Equity |
|
|
|
|
|
||||
Series A non-cumulative preferred stock and additional paid in capital, |
|
|
533 |
|
|
|
533 |
|
|
Common stock; 1,000,000,000 shares authorized, |
|
|
1 |
|
|
|
1 |
|
|
Additional paid-in capital |
|
|
6,025 |
|
|
|
6,005 |
|
|
|
|
|
(909 |
) |
|
|
(599 |
) |
|
Accumulated other comprehensive income (loss), net of tax expense (benefit) of |
|
|
(2,383 |
) |
|
|
(2,808 |
) |
|
Retained earnings |
|
|
7,431 |
|
|
|
7,038 |
|
|
Total shareholders' equity |
|
|
10,698 |
|
|
|
10,170 |
|
|
Noncontrolling interests |
|
|
209 |
|
|
|
164 |
|
|
Total equity |
|
|
10,907 |
|
|
|
10,334 |
|
|
Total liabilities and equity |
|
|
345,662 |
|
|
|
330,255 |
|
|
Condensed Consolidated Income Statements
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
||||||||||||
(in millions, except per share data) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
||||||||
Revenues |
|
|
|
|
|
|
|
|
|
||||||||
Fee income |
|
$ |
2,032 |
|
|
$ |
1,950 |
|
|
$ |
6,038 |
|
|
$ |
5,751 |
|
|
Premiums |
|
|
31 |
|
|
|
32 |
|
|
|
106 |
|
|
|
109 |
|
|
Net investment income: |
|
|
|
|
|
|
|
|
|
||||||||
Net investment income excluding funds withheld assets |
|
|
457 |
|
|
|
458 |
|
|
|
1,384 |
|
|
|
1,248 |
|
|
Net investment income on funds withheld assets |
|
|
269 |
|
|
|
303 |
|
|
|
824 |
|
|
|
862 |
|
|
Total net investment income |
|
|
726 |
|
|
|
761 |
|
|
|
2,208 |
|
|
|
2,110 |
|
|
Net gains (losses) on derivatives and investments: |
|
|
|
|
|
|
|
|
|
||||||||
Net gains (losses) on derivatives and investments |
|
|
102 |
|
|
|
(335 |
) |
|
|
(4,132 |
) |
|
|
(5,173 |
) |
|
Net gains (losses) on funds withheld reinsurance treaties |
|
|
(784 |
) |
|
|
159 |
|
|
|
(1,199 |
) |
|
|
(648 |
) |
|
Total net gains (losses) on derivatives and investments |
|
|
(682 |
) |
|
|
(176 |
) |
|
|
(5,331 |
) |
|
|
(5,821 |
) |
|
Other income |
|
|
14 |
|
|
|
18 |
|
|
|
25 |
|
|
|
52 |
|
|
Total revenues |
|
|
2,121 |
|
|
|
2,585 |
|
|
|
3,046 |
|
|
|
2,201 |
|
|
|
|
|
|
|
|
|
|||||||||||
Benefits and Expenses |
|
|
|
|
|
|
|
|
|
||||||||
Death, other policy benefits and change in policy reserves, net of deferrals |
|
|
209 |
|
|
|
232 |
|
|
|
639 |
|
|
|
701 |
|
|
(Gain) loss from updating future policy benefits cash flow assumptions, net |
|
|
— |
|
|
|
(1 |
) |
|
|
(7 |
) |
|
|
23 |
|
|
Market risk benefits (gains) losses, net |
|
|
1,172 |
|
|
|
(2,376 |
) |
|
|
(2,062 |
) |
|
|
(5,120 |
) |
|
Interest credited on other contract holder funds, net of deferrals and amortization |
|
|
275 |
|
|
|
284 |
|
|
|
821 |
|
|
|
864 |
|
|
Interest expense |
|
|
25 |
|
|
|
28 |
|
|
|
76 |
|
|
|
84 |
|
|
Operating costs and other expenses, net of deferrals |
|
|
742 |
|
|
|
626 |
|
|
|
2,105 |
|
|
|
1,862 |
|
|
Amortization of deferred acquisition costs |
|
|
277 |
|
|
|
290 |
|
|
|
832 |
|
|
|
874 |
|
|
Total benefits and expenses |
|
|
2,700 |
|
|
|
(917 |
) |
|
|
2,404 |
|
|
|
(712 |
) |
|
Pretax income (loss) |
|
|
(579 |
) |
|
|
3,502 |
|
|
|
642 |
|
|
|
2,913 |
|
|
Income tax expense (benefit) |
|
|
(113 |
) |
|
|
712 |
|
|
|
24 |
|
|
|
399 |
|
|
Net income (loss) |
|
|
(466 |
) |
|
|
2,790 |
|
|
|
618 |
|
|
|
2,514 |
|
|
Less: Net income (loss) attributable to noncontrolling interests |
|
|
3 |
|
|
|
17 |
|
|
|
17 |
|
|
|
21 |
|
|
Net income (loss) attributable to |
|
|
(469 |
) |
|
|
2,773 |
|
|
|
601 |
|
|
|
2,493 |
|
|
Less: Dividends on preferred stock |
|
|
11 |
|
|
|
11 |
|
|
|
33 |
|
|
|
24 |
|
|
Net income (loss) attributable to |
|
$ |
(480 |
) |
|
$ |
2,762 |
|
|
$ |
568 |
|
|
$ |
2,469 |
|
|
|
|
|
|
|
|
|
|||||||||||
Earnings per share |
|
|
|
|
|
|
|
|
|
||||||||
Basic |
|
$ |
(6.37 |
) |
|
$ |
33.66 |
|
|
$ |
7.41 |
|
|
$ |
29.95 |
|
|
Diluted1 |
|
$ |
(6.37 |
) |
|
$ |
33.35 |
|
|
$ |
7.34 |
|
|
$ |
29.20 |
|
|
(1) If we reported a net loss attributable to |
_______________________
1 For the reconciliation of non-GAAP measures to the most comparable
2 For the reconciliation of non-GAAP measures to the most comparable
3 See reconciliation of Net Income to Total Pretax Adjusted Operating Earnings in the Appendix to this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241106483008/en/
Investor Relations Contacts:
elizabeth.werner@jackson.com
andrew.campbell@jackson.com
Media Contact:
patrick.rich@jackson.com
Source: